Asymptomatic Atrial Fibrillation: The Case for Screening to Prevent Stroke

JAMA. 2015 Nov 10;314(18):1911-2. doi: 10.1001/jama.2015.9846.

Authors

S Ben Freedman¹, Nicole Lowres¹

Affiliation

¹ Sydney Medical School, The University of Sydney, Sydney, Australia2Department of Cardiology, Concord Hospital, Sydney, Australia3Anzac Research Institute, Concord, Sydney, Australia.

PMID: 26547457
DOI: 10.1001/jama.2015.9846

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Aged
Anticoagulants / therapeutic use*
Asymptomatic Diseases*
Atrial Fibrillation / complications
Atrial Fibrillation / diagnosis*
Atrial Fibrillation / economics
Cost-Benefit Analysis
Humans
Incidental Findings
Mass Screening / statistics & numerical data
Pulse
Stroke / etiology
Stroke / prevention & control*

Substances

Anticoagulants